Poland URPL

Guidance on qualification and classification of safety wristbands used in telecare services and recognition as medical devices

Guidance on how to qualify and classify safety wristbands used in telecare services as medical devices and their regulatory classification.

125th Heads of Medicines Agencies meeting in Dublin under Irish EU presidency

W dniach 6–7 października 2026 r. w Dublinie odbyły się obrady plenarne 125. posiedzenia Heads of Medicines Agencies (HMA), organizowanego w ramach irlandzkiej prezydencji w Radzie Unii Europejskiej. Polskę reprezento...

133rd Meeting of the EMA Management Board

W dniu 30 września 2026 r. odbyło się 133. posiedzenie Rady Zarządzającej Europejskiej Agencji Leków (EMA) w formule wirtualnej. Polskę reprezentował Prezes Urzędu Rejestracji Produktów Leczniczych, Wyrobów Medycznych...

Call for offers: sale of Polish Pharmacopoeia editions XIV and XIII on commission basis

Prezes Urzędu Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych, do którego zadań należy opracowywanie i wydawanie Farmakopei Polskiej, zaprasza do składania ofert w przedmiocie sprzedaż, n...

Information from the President of URPL on World Patient Safety Day 2026 – 'Safety of therapy in chronic diseases – the patient as a partner in obesity treatment'

Poland's World Patient Safety Day 2026 campaign focuses on therapy safety in chronic diseases and patient partnership in obesity treatment.

Information from the President of URPL on the CMDh Coordination Group meeting of 21-22 July 2026

CMDh coordination group concluded benefit-risk ratio of valproate-containing medicinal products remains unchanged; marketing authorisation holders requested to submit Type II C.9.c variation within 6 months.

URPL President participates in 100th anniversary celebration of the Faculty of Pharmacy at the Medical University of Warsaw

URPL experts educate young people on safe medicine use

Notice: Polish Office of Medicinal Products, Medical Devices and Biocidal Products closure on 14 August 2026

W związku z postanowieniami Zarządzenia nr 2 Prezesa Rady Ministrów z dnia 5 stycznia 2026 r. w sprawie wyznaczenia dla członków korpusu służby cywilnej dni wolnych od pracy, informujemy, że w dniu 14 sierpnia 2026 r....

132nd meeting of the Management Board of the European Medicines Agency

Information from the President of URPL on the translation of recommendations from the European Commission Expert Group on Veterinary Medicinal Products concerning the use of veterinary medicinal products in accordance with Articles 112-114 of Regulation (EU) 2019/6

URPL President's Notice of 29 June 2026 on supplements to the EDQM Standard Terms database

Notice of the President of URPL of 22 June 2026 on new and amended chapters and monographs in the European Pharmacopoeia 12.3

URPL President's Information on the Annual Report of the President of the Office for the Registration of Medicinal Products, Medical Devices and Biocidal Products for 2025

Information from the President of URPL of 25 June 2026 on the distribution of the Polish Pharmacopoeia, 12th edition

Information from the President of URPL on the CMDh Coordination Group meeting, 23–25 June 2026

Availability of Supplement 2025 to the Polish Pharmacopoeia, 13th Edition

Electronic version of Polish Pharmacopoeia XIII with Supplement 2025 is out of stock; printed version available from Cogno Medical.

Polish Pharmacopoeia XIII: Supplement 2025 – electronic version availability notice

Electronic version of Polish Pharmacopoeia XIII cumulative edition with 2024 and 2025 supplements now available for purchase; print edition exhausted.